Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
Deloitte
AstraZeneca
Baxter
Chinese Patent Office

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 8,187,612

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,187,612
Title:Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G.
Inventor(s): Aoki; Kei Roger (Coto De Caza, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (San Mateo, CA), Leon; Judith M. (San Juan Capistrano, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:10/726,904
Patent Claims:see list of patent claims

Details for Patent 8,187,612

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 ➤ Sign Up Allergan, Inc. (Irvine, CA) 2013-12-28 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,187,612

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 9517904 Jul 06, 1995
World Intellectual Property Organization (WIPO) 9517904 Oct 19, 1995
United States of America 2001018415 Aug 30, 2001
United States of America 2001041181 Nov 15, 2001
United States of America 2001043930 Nov 22, 2001
United States of America 2001053364 Dec 20, 2001
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Baxter
McKesson
Citi
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.